In NSCLC patients, the high expression of Ki67, VEGF-A, and VEGF-C is associated with an increased risk of lymph node metastasis, while VEGF-D was not correlated with lymph node metastasis. The gene discussed is MKI67; the disease is metastatic malignant neoplasm in the lymph nodes.